Penny Stocks News (NYSE, NASDAQ, NYSEMKT)

Find the hidden catayst
Scan all pennies at once

PublishedDate (EST) Title
1/16/2018 2:14:12 PM     is now the time to bet on the tech sector and cbak energy technology inc (nasdaq:cbak)?
1/16/2018 8:49:00 AM     camtek receives an order of over $5m for multiple systems
1/16/2018 7:00:00 AM     HOT !!:capricor announces licensing of additional patent applications from cedars-sinai medical center for cellular and exosome-based technologies
1/12/2018 10:00:00 AM     camtek ltd. (nasdaq: camt) to ring the nasdaq stock market closing bell
1/11/2018 7:40:00 AM     wired news – camtek gets multiple orders for its next generation 3d metrology system
1/11/2018 7:00:00 AM     can-fite 12 months' activities & milestones for 2018
1/10/2018 9:00:00 AM     HOT !!:copperbank and the aleut corporation extend pyramid and san diego bay exploration agreements
1/9/2018 10:42:03 AM     HOT !!:amgen announces acceptance of maa for evenity in europe
1/9/2018 10:03:14 AM     what you must know about camtek ltd’s (nasdaq:camt) return on equity
1/9/2018 7:23:11 AM     what you must know about cbak energy technology inc’s (nasdaq:cbak) major investors
1/9/2018 6:28:00 AM     camtek receives orders for 17 tools of its next generation 3d metrology system
1/8/2018 5:54:10 PM     HOT !!:ultragenyx announces interim data from early stage study
1/8/2018 8:00:00 AM     cymabay therapeutics receives $5 million milestone payment for arhalofenate from kowa pharmaceuticals america
1/8/2018 8:00:00 AM     enrollment begins in long-term extension study of seladelpar in patients with primary biliary cholangitis
1/8/2018 7:40:00 AM     HOT !!:can-fite signs multi-million dollar distribution agreement for piclidenoson in 3 european countries with gebro holdings
1/5/2018 4:57:05 AM     stock rally driven by momentum trades, says kettner
1/4/2018 10:59:00 AM     camtek to present at the needham growth conference on january 17 and ring the nasdaq closing bell on january 16
1/4/2018 9:21:01 AM     casmed reports preliminary net sales for the 2017 fourth quarter
1/4/2018 8:00:00 AM     catalyst biosciences initiates phase 2/3 trial of marzeptacog alfa (activated) for prophylaxis in hemophilia a or b with inhibitors
1/3/2018 11:12:00 AM     cse new listing - fincanna capital commences trading on the canadian securities exchange - video news alert on